Statistics
Publications
19
Citations
3.1K
H-Index
18
Active since
2000
Peter E. Soden is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, neuroscience, and neurodegenerative diseases.
Publications per year
2000–2021
19
19
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson, Rab K. Prinjha, Antje Dittmann et al. · Nature · 2011 · 1.5K citations · Full text
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 428 citations · Full text
Amritpal Mudher, Susan C. Chapman, Jill Richardson et al. · Journal of Neuroscience · 2001 · 119 citations · Full text
1–5 of 19